Saxagliptin - third gliptin on the EU market
October 8, 2009
ONGLYZA™ (saxagliptin) Receives Marketing Authorisation In Europe For The Treatment Of Type 2 Diabetes | www.pipelinereview.com
Besides Sitagliptin and Vildagliptin there will be now a 3rd gliptin available in Europe. Whereas vildagliptin officially needs monitoring of the liver enzymes, at least according to the P.I., and there are new warnings for pancreatitis for sitagliptin no such limitations are known to me at the moment....
No real support for government healthcare
July 23, 2009
AMA Endorses House Democrats' Health Care Bill | www.businessweek.com
Evidently whoever is incharge of AMA policy is into stimulus pork policy. I do not know of one Doctor in my entire 100 mile radius that endorses this BOONDOGLE. It is simply a joke and every physician knows it. The only way AMA would even consider this is if some group is getting offered a policy position....
June 23, 2009
Presdient Obama creates health reform office | fcw.com
President Obama has no concept how to manage the change needed in the Healthcare arena. He has brought together some IVY League Doctors who live in Federally funded boxes. The real US healthcare dilema still exists simply because they have no clue how to fix it. Politics will not make a dent in the...
Roche adds to anti-MRSA arsenal in Europe
April 8, 2009
Roche introduces new LightCycler MRSA advanced test in EU | www.roche.com
European healthcare organizations have always been more aggressive in identifying MRSA infections. Europe popularized the "search and destroy" protocol of MRSA containment. This new method by Roche is a valuable addition in this arsenal. I expect the LightCycler MRSA Test by Roche to be popular...
A Low Cost EMR System From Wal-Mart?
March 16, 2009
Wal-Mart Plans to Market Digital Health Records System | www.nytimes.com
Wal-Mart is one of the top consumer retailers in the country. They have already entered the world of competitive, low cost health care delivery with their $4.00 generic prescriptions and their Nurse Practitioner run clinics--so becoming a warehouse for state-of-the-art electronic medical...
Health Care in America--An Ailing Commodity That Doctors Can't Cure
January 30, 2009
Perspectives on Health Reform, 17th January 2009 | healthaffairs.org
Fixing the health care system in America is like trying to fix the economy. We keep dumping more and more money into it, only to find ourselves going nowhere. There seems to be a renewed sense of hope with the emergence of a new administration in Washington, but there are no easy solutions. ...
High End Medical Devices and Implants Are Not Immune to This Recession
January 22, 2009
Medical devices not immune to recession worries | www.boston.com
As America faces one of the worst recessions in history, all businesses suffer, including the health care industry. With the steady rise of unemployment, more and more people are losing their jobs, and with it their health insurance. This has a direct impact on medical devicecompanies,...
January 15, 2009
Health-Care Outlays Climb at Slowest Rate in Years | online.wsj.com
The reason for healthcare costs slowing is in the drug area. A second more unintended reason is reduction in illegal residents returning to their home country due to the down turn in the economy. Also cuts in Home care have also increased along with a more fruitful Fraud and Abuse effort which wasramped...
Bold Contest for a Daunting Problem
October 27, 2008
WellPoint, X Prize launch $10M health care contest | news.yahoo.com
Most people agree that the healthcare system in the United States is in need of a complete overhaul. Unfortunately, the many competing interests in the current system make such overhaul extremely challenging. This contest certainly provides much incentive for the...
Life-extending effect of Byetta ?
August 13, 2008
Lilly Diabetes Drug Shows a Life-Extending Promise | www.nytimes.com
In a small subgroup of type-2-diabetes patients in the ACCORD trial which had been treated with Byetta (825 of 10 000) a lowerde death rate was found as compared to the whole group. This is a hypothesis-generating finding. Fewer hypoglycemias, even mild ones, may be an exüplanation forthis...
FDA Publishes H1N1 Diagnostic Test Guidance
November 5, 2009
Synta Drug for Metastatic Melanoma Not Dead Yet (?)
November 3, 2009
Pharma Outsourcing: Where Will it End?
November 3, 2009
Delcath Phase III trial for metastatic melanoma completes enrollment
November 3, 2009
Healthy if You're Wealthy: Ghana offers Choices
November 2, 2009
www.reuters.com
www.businesswire.com
Synta Pharmaceuticals Announces Updated Elesclomol SYMMETRYSM Data Presented at Melanoma XIII
www.outsourcing-pharma.com
www.genomeweb.com
www.pharmabiz.com
Novartis to invest US$ 1 bn to build largest pharma R&D institute in China